Spironolactone for Pulmonary Arterial Hypertension

NCT01712620 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

NIH

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]